Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.061 0.06
mRNA VX-11e GDSC1000 pan-cancer AAC -0.063 0.06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA MG-132 GDSC1000 pan-cancer AAC -0.098 0.06
mRNA Erlotinib CCLE pan-cancer AAC -0.085 0.07
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.06 0.07
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.064 0.07
mRNA rTRAIL GDSC1000 pan-cancer AAC -0.065 0.07
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.06 0.07
Download CSV